[根据UPLC-Q-TOF-MS进行的Berberidis Radix在中介性性结肠炎中的代谢学研究]
Xue-Li Hu1, Chang-Yuan Zhou2, Rui Xu3
1Hubei Key Laboratory of Biological Resources Protection and Utilization, Hubei Minzu University Enshi 445000, China Hubei Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Hubei Minzu University Enshi 445000, China Medical School, Hubei Minzu University Enshi 445000, China.
概括
伯贝里迪斯Radix通过调节脂质和氨基酸代谢,显著改善了小鼠的性结肠炎 (UC) 症状. 这种传统的Tujia药物在炎症期间恢复新陈代谢平衡方面表现出潜力.
科学领域:
- 代谢学 代谢学 代谢学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,治疗选择有限.
- 硫酸德克斯 (DSS) 通常用于诱导研究小鼠的UC模型.
- 了解UC的潜在代谢机制对于开发有效疗法至关重要.
研究的目的:
- 在DSS诱导的UC小鼠模型中研究Berberidis Radix对内源代谢物的作用.
- 探索Berberidis Radix干预UC的代谢途径和机制.
- 评估Berberidis Radix在UC的治疗潜力.
主要方法:
- 在小鼠中使用DSS诱导UC,并给予Berberidis Radix.
- 评估临床症状,疾病活动指数 (DAI) 和结肠长度.
- 使用ELISA对炎症标志物 (TNF-α,IL-10) 的量化.
- 使用UPLC-Q-TOF-MS进行血清和便的代谢分析.
- 统计分析包括PCA,OPLS-DA,并通过MetaboAnalyst 5.0.0进行途径分析.
主要成果:
- 贝贝里迪斯拉迪克斯显著改善了UC症状,并增加了抗炎IL-10水平.
- 代谢学发现了血清中的56种不同代谢物和便中的43种,包括脂质和氨基酸.
- 贝贝里迪斯的Radix干预导致了代谢障碍的逐渐恢复.
- 主要受影响的代谢途径包括氨基酸生物合成,酸代谢和甘氨酸脂代谢.
结论:
- 贝贝里迪斯 (Berberidis Radix) 证明了在小鼠中减轻DSS诱导的UC的治疗潜力.
- 该机制涉及脂质,氨基酸和能量代谢的调节.
- 代谢学提供了关于Berberidis Radix对UC的药理学影响的宝贵见解.
相关概念视频
01:19MALDI-TOF Mass Spectrometry
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...